Biography and Research Information
OverviewAI-generated summary
Kariomot O. Shobowale's research focuses on the application of artificial intelligence to predict chemotherapy resistance in Triple-Negative Breast Cancer (TNBC). This work involves developing multimodal integration strategies to enhance predictive accuracy. Shobowale has published multiple articles on this subject, with the most recent publications dating to 2025. The researcher's work contributes to the growing body of literature utilizing computational methods for improved cancer treatment strategies.
Metrics
- Publications: 3
Selected Publications
-
Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy (2025)
-
Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy (2025)
Collaboration Network
Top Collaborators
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
- Artificial Intelligence Approaches to Predict Chemotherapy Resistance in Triple-Negative Breast Cancer (TNBC): A Multimodal Integration Strategy
Similar Researchers
Based on overlapping research topics